Literature DB >> 31057733

Origin and bioactivities of thiosulfinated FK228.

Xiangyang Liu1, Grant C Currens1, Liang Xue2, Yi-Qiang Cheng1.   

Abstract

During a large laboratory-scale purification of FK228 from the fermentation broth of Burkholderia thailandensis MSMB43, a small amount of thiosulfinated FK228 (TS-FK228) was unexpectedly purified only after the broth was mixed with silica gel. Evidence supports the postulations that TS-FK228 was derived from FK228 through spontaneous chemical reaction with silica gel, and TS-FK228 existed as two isomers 1 and 2. TS-FK228 demonstrated similar inhibitory activity and profile against human class I histone deacetylases but exhibited a much higher antiproliferative activity against representative human cancer cell lines when compared to FK228.

Entities:  

Year:  2019        PMID: 31057733      PMCID: PMC6482872          DOI: 10.1039/c9md00060g

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  33 in total

1.  FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases.

Authors:  Ryohei Furumai; Akihisa Matsuyama; Nobuyuki Kobashi; Kun-Hyung Lee; Makoto Nishiyama; Hidenori Nakajima; Akito Tanaka; Yasuhiko Komatsu; Norikazu Nishino; Minoru Yoshida; Sueharu Horinouchi
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

2.  Reconstitution of the FK228 biosynthetic pathway reveals cross talk between modular polyketide synthases and fatty acid synthase.

Authors:  Shane R Wesener; Vishwakanth Y Potharla; Yi-Qiang Cheng
Journal:  Appl Environ Microbiol       Date:  2010-12-23       Impact factor: 4.792

Review 3.  Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine.

Authors:  P S Suresh; V C Devaraj; Nuggehally R Srinivas; Ramesh Mullangi
Journal:  Biomed Chromatogr       Date:  2016-09-13       Impact factor: 1.902

4.  S-methyl methane thiosulfonate, a new antimutagenic compound isolated from Brassica oleracea L. var. botrytis.

Authors:  Y Nakamura; T Matsuo; K Shimoi; Y Nakamura; I Tomita
Journal:  Biol Pharm Bull       Date:  1993-02       Impact factor: 2.233

5.  Tandem allylic oxidation-condensation/esterification catalyzed by silica gel: an expeditious approach towards antimalarial diaryldienones and enones from natural methoxylated phenylpropenes.

Authors:  Abhishek Sharma; Naina Sharma; Amit Shard; Rakesh Kumar; Dinesh Mohanakrishnan; Arun K Sinha; Dinkar Sahal
Journal:  Org Biomol Chem       Date:  2011-05-31       Impact factor: 3.876

6.  FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. III. Antitumor activities on experimental tumors in mice.

Authors:  H Ueda; T Manda; S Matsumoto; S Mukumoto; F Nishigaki; I Kawamura; K Shimomura
Journal:  J Antibiot (Tokyo)       Date:  1994-03       Impact factor: 2.649

7.  In vitro toxicological assessment of an organosulfur compound from Allium extract: Cytotoxicity, mutagenicity and genotoxicity studies.

Authors:  Pilar Mellado-García; Sara Maisanaba; María Puerto; Ana Isabel Prieto; Ricard Marcos; Silvia Pichardo; Ana María Cameán
Journal:  Food Chem Toxicol       Date:  2016-12-08       Impact factor: 6.023

8.  An FAD-dependent pyridine nucleotide-disulfide oxidoreductase is involved in disulfide bond formation in FK228 anticancer depsipeptide.

Authors:  Cheng Wang; Shane R Wesener; Hailong Zhang; Yi-Qiang Cheng
Journal:  Chem Biol       Date:  2009-06-26

9.  Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells.

Authors:  Benigno C Valdez; Yang Li; David Murray; Yan Liu; Yago Nieto; Richard E Champlin; Borje S Andersson
Journal:  Oncotarget       Date:  2017-12-17

Review 10.  Use of class I histone deacetylase inhibitor romidepsin in combination regimens.

Authors:  Adam Petrich; Chadi Nabhan
Journal:  Leuk Lymphoma       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.